Last reviewed · How we verify
Compound lidocaine — Competitive Intelligence Brief
marketed
Local anesthetic
Voltage-gated sodium channels
Anesthesia
Small molecule
Live · refreshed every 30 min
Target snapshot
Compound lidocaine (Compound lidocaine) — Tianjin Medical University General Hospital. Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses to produce local anesthesia.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Compound lidocaine TARGET | Compound lidocaine | Tianjin Medical University General Hospital | marketed | Local anesthetic | Voltage-gated sodium channels | |
| levobupivacaine bolus dosing | levobupivacaine bolus dosing | Kuopio University Hospital | marketed | Local anesthetic (amide) | Voltage-gated sodium channels | |
| Topical anesthetic | Topical anesthetic | University of Campinas, Brazil | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Lidocaine 5% patch | Lidocaine 5% patch | Beijing Tiantan Hospital | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Buffered Articaine Hydrochloride + Epinephrine | Buffered Articaine Hydrochloride + Epinephrine | Ohio State University | marketed | Local anesthetic with vasoconstrictor | Voltage-gated sodium channels; alpha-1 adrenergic receptors (epinephrine component) | |
| Articaine Hydrochloride + Epinephrine | Articaine Hydrochloride + Epinephrine | Ankara Yildirim Beyazıt University | marketed | Local anesthetic with vasoconstrictor | Voltage-gated sodium channels; alpha-1 adrenergic receptors (epinephrine component) | |
| carbamazepine oxcarbazepine | carbamazepine oxcarbazepine | Odense University Hospital | marketed | Anticonvulsant / Antiepileptic agent | Voltage-gated sodium channels |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic class)
- University of California, San Diego · 3 drugs in this class
- Durect · 3 drugs in this class
- Pacira Pharmaceuticals, Inc · 3 drugs in this class
- Wake Forest University Health Sciences · 3 drugs in this class
- Medical University of Vienna · 3 drugs in this class
- Imperial College London · 2 drugs in this class
- Hvidovre University Hospital · 2 drugs in this class
- Innocoll · 2 drugs in this class
- George Washington University · 2 drugs in this class
- Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Compound lidocaine CI watch — RSS
- Compound lidocaine CI watch — Atom
- Compound lidocaine CI watch — JSON
- Compound lidocaine alone — RSS
- Whole Local anesthetic class — RSS
Cite this brief
Drug Landscape (2026). Compound lidocaine — Competitive Intelligence Brief. https://druglandscape.com/ci/compound-lidocaine. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing